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Membranes and Model Membranes: Functional Assays
and Role for Peripherin/rds
B y KATHLEEN BOESZE-BATTAGLIA

Introduction
Membrane fusion is defined as the consolidation of two membrane
bilayers and a subsequent mixing of the two previously separated aqueous
compartments. Membrane fusion processes are mediated and regulated by
a growing family of soluble and integral membrane proteins termed fusion
proteins. I'2 Fusion proteins share structural and functional properties and
aid in the thermodynamically unfavorable fusion event by promoting hydrophobic interactions that favor fusion. I-3
Within retinal photoreceptor rod cells membrane fusion is a component
step of at least three essential cellular processes. Fusion is necessary for
the delivery of proteins and lipids in vesicles from the rod inner segment
(site of synthesis) to the rod outer segment (ROS). Two additional fusion
processes preserve the unique architecture of the outer segment by maintaining the outer segment at a constant length. The coordinated processes
of disk morphogenesis and compensatory disk shedding 4 require the fusion
of two opposing membranes: the fusion of two outgrowing inside-out disk
rims for morphogenesis, 5 and disk-plasma membrane fusion for disk packet
formation. 6 Fusion during disk packet formation is documented in microscopy studies in which an analysis of dye penetration into distinct regions
of the ROS found that large molecules do not enter the narrow bands
of the dye-stained region of the ROS, suggesting a fusion of the plasma
membrane with the disk membranes. 7'8 This fusion is mediated by a
fusion protein unique to photoreceptors: peripherin/rds. In this chapter
we describe the protocols used in photoreceptor cell-free fusion assays
t N. Diizgtine~, in "Subcellular Biochemistry" (D. Roodyn, ed.), p. 195. Plenum Press, London, 1985.
z E. Pecheur, J. SainteMarie, A. Bienvenue, and D. Hoekstra, Z Membr. Biol. 167, 1 (1999).
3 j. M. White, Science 258, 917 (1992).
4 R. W. Young, Invest. Ophthalmol. Vis. Sci. 15, 700 (1976).
5 R. H. Steinberg, S. K. Fisher, and D. H. Anderson, J. Comp. Neurol. 190, 501 (1980).
6 K. Boesze-Battaglia, A. D. Albert, and P. L. Yeagle, Biochemistry 31, 3733 (1992).
7 B. Matsumoto and J. C. Besharse, Invest. Ophthalmol. Vis. Sci. 26, 628 (1985).
8 j. C. Besharse and G. Hageman, Invest. Ophthalmol. Vis. Sci. 31, 57 (1990).
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and the characterization of peripherin/rds as a rod cell-specific fusion
protein.6, 9-13

G e n e r a l Principles Involved in D e s i g n of F u s i o n A s s a y s
M e m b r a n e fusion must satisfy two criteria: (1) the merger of two m e m b r a n e bilayers and (2) the subsequent mixing of the aqueous contentsJ 4
To characterize the molecular mechanism of fusion, it is necessary to evaluate the two p h e n o m e n a separately by distinct albeit c o m p l e m e n t a r y techniques. In biological systems, the m e a s u r e m e n t of aqueous contents mixing
is often difficult or impossible to achieve and thus is often inferred f r o m
the detection of lipid mixing. Unfortunately, the formation of a fusion
p o r e independent of aqueous contents mixing (i.e., hemifusion), can be
misinterpreted as fusion, ts The careful design and rigorous interpretation
of control experiments avoid such misinterpretations. A q u e o u s contents
mixing in some biological systems is now detectable with the d e v e l o p m e n t
of molecular genetics techniques that rely on the cytoplasmic activation of
r e p o r t e r genes on fusion of two distinct cell populations. 16 Fusion processes
are measured in vitro by a variety of techniques described elsewhere, lv,ls
The most sensitive and reliable m e a s u r e m e n t s of the kinetics of a fusion
process require biophysical techniques, 19 the most well characterized of
which is fluorescence spectroscopy. Fluorescence-based biological fusion
assays are broadly divided into two categories: p r o b e dilution 2° and resonance energy transfer, 21 both of which measure the mixing of the lipids
within the m e m b r a n e s . Both of these techniques have b e e n utilized in the
design of p h o t o r e c e p t o r specific cell-free fusion assays.
9 K. Boesze-Battaglia, F. Kong, O. P. Lamba, F. P. Stefano, and D. S. Williams, Biochemistry

22, 6835 (1997).
10K. Boesze-Battaglia, O. P. Lamba, A. Napoli, S. Sinha, and Y. Guo, Biochemistry 37,
9477 (1998).
11K. Boesze-Battaglia, Invest. Ophthalmol. Vis. Sci. 38, 487 (1997)
12K. Boesze-Battaglia and P. L. Yeagle, Invest. Ophthalmol. Vis. Sci. 33, 484 (1992).
13K. Boesze-Battaglia, F. P. Stefano, M. Fenner, and A. A. Napoli, Jr., Biochim. Biophys.
Acta, in press (2000).
14E. m. Liberman and V. A. Nenashev, Biofizika 13, 193 (1968).
is j. R. Monck and J. M. Fernandez, Curr. Opin. Cell BioL 8, 524 (1996).
16O. Nussbaum, C. C. Broder, and E. A. Berger, J. Virol. 68, 5411 (1994).
17N. Dtizgtine§, Methods Enzymol. 2287 (1993).
is N. Dtizgtine§, Methods Enzymol. 221, (1993).
19N. Dttzgt~ne§, J. Wilschut, and D. Papahadjopoulos, in "Physical Methods in Biological
Membranes and Their Model Systems" (F. Conti, W. E. Blumberg, J. DeGier, and F.
Pocchiari, eds.), p. 193. Plenum, New York, 1985.
20p. M. Keller, S. Person, and W. Snipes, J. Cell Sci. 28, 167 (1977).
21D. Hoekstra, T. D. Boer, K. Klappe, and J. Wilschut, Biochemistry 23, 5675 (1984).
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Rod Outer Segment Membrane Fusion
In practice, lipid mixing is measured by the incorporation of a fluorescent
probe into the membrane bilayer and a change in fluorescence emission,
accessed either through resonance energy transfer pairs, or via a release
of self-quenching, on fusion of the labeled membrane with a suitable target
membrane. In photoreceptors, the fusion assay used most often is based
on a relief of octadecylrhodamine B chloride (Rls) self-quenching as two
membrane bilayers mix. When the R18-1abeled membrane fuses with unlabeled target membrane, the lipid-like probe is effectively diluted by its
subsequent lateral diffusion within the target membrane. Probe dilution is
detected as a progressive linear increase in fluorescence intensity, which is
proportional to the extent of fusion,zl This technique allows kinetic and
quantitative measurements of fusion between labeled membranes and both
artificial and biological membranes. 19-21 The typical protocol for R18 labeling of bovine ROS plasma membrane and ensuing fusion follows.
Preparation and Labeling o f R o d Outer Segment Plasma Membrane
Materials

Purified ROS plasma membrane vesicles
Octadecylrhodamine B chloride (R18; Molecular Probes, Eugene, OR)
Sephadex G-75 (Pharmacia, Piscataway, NJ)
Column buffer: 100 mM NaCI, 10 mM glycine, 0.1 mM EDTA, pH 7.5
Calcium chelating buffer: 5 mM HEPES, 1 mM EDTA, pH 7.4
ROS disks and plasma membranes are isolated from either fresh or frozen
bovine retinas. 22The plasma membrane vesicles are purified free from ROS
disk membranes by binding to ricinl20-agarose (Sigma, St. Louis, MO) and
separated by continuous sucrose density gradient centrifugation,z2The ROS
plasma membrane bound to ricin-agarose is recovered as a pellet in the
gradient. The plasma membrane is eluted from the ricin-agarose in a
Pasteur pipette column with 1 M galactose in 0.1 M sodium borate, pH
8.0. The resulting plasma membrane vesicles are washed free of galactose
(spin at 50,000 rpm for 40 min at 10°) and resuspended in calcium chelating
buffer. 23 The phospholipid content of the membrane is determined24,25
and the final concentration adjusted to 2.0 mM phosphate. ROS plasma
membrane vesicles must be labeled and used within a 24-hr period; otherwise vesicles become leaky and give spurious results. Both the preparation
22K. Boesze-Battagliaand A. D. Albert, Exp. Eye Res. 49, 699 (1989).
23S. Robertson and J. Potter, J. PharmacoL 5, 63 (1984).
24G. R. Bartlett,J. Biol. Chem. 234, 466 (1959).
25B. J. Litman,Biochemistry 13, 2545 (1973).
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and labeling of the ROS plasma membrane are performed under dim
red light.

Rls Labeling of Rod Outer Segment Plasma Membrane
The freshly isolated ROS plasma membrane vesicles are labeled with
R18 .6 A stock solution of R18 (10 mg/ml) is prepared in chloroformmethanol (1:1, v/v) and stored at - 2 0 °. An aliquot of this solution is
removed, dried under a stream of nitrogen, and reconstituted in a minimal
volume of ethanol. R18 is incorporated into the ROS plasma membrane
at self-quenching concentrations, equivalent to approximately 5 mol% relative to the phospholipid content of the ROS plasma membrane. Typically,
a 2-ml suspension of ROS plasma membrane (rhodopsin concentration,
1 mg/ml) is added to 10/zl of 10 nmol of R18, in ethanol, under vigorous
vortexing. Since the final incubation volume is 2 ml, the final ethanol
concentration is less than 1% (v/v). The mixture is rocked gently at room
temperature for 30-60 min in the dark. 6
The unincorporated probe is removed by chromatography on a Sephadex G-75 column (total volume of the column, 3-4 ml). The unincorporated
R~8 adsorbs to the top of the column, and the R18-1abeled plasma membrane
is recovered in the void volume and identified by absorbance at 214 nm.
Free probe can also be removed with bovine serum albumin, ~ followed
by sucrose density gradient centrifugation. In addition to being more time
consuming, the bovine serum albumin (BSA) procedure may also remove
membrane lipids and alter bilayer properties. For the remainder of this
chapter R18-1abeled plasma membrane is abbreviated as R18-PM. To quantitate the incorporation of R18 into the plasma membrane, the labeled vesicles
are extracted with chloroform-methanol (2 : 1). 26The fluorescence intensity
of an aliquot of the extract is measured and compared with the intensity
of known amounts of R18 in chloroform, which increase linearly up to
concentrations of 1 nmol/ml. 27

Preparation of Target Membranes
The accurate measurement of membrane fusion processes by relief of
self-quenching requires that the concentration of target membrane be at
least 30- to 100-fold greater than that of the R18-1abeled species. 28 In our
experiments a surface area ratio between R18-PM and target membranes
of 1 : 50 or 1 : 100 yields satisfactory results, although the ratio of labeled
26 j. Folch, M. Lees, and M. G. A. Sloane-Stanley, J. Biol. Chem. 226, 497 (1957).
27 D. Hoekstra and K. Klappe, J. Virol. 58, 87 (1986).
28 M. J. Clague, C. Schoch, L. Zech, and R. Blumenthal, Biochemistry 29, 1303 (1990).
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membrane to unlabeled membrane should be optimized for each system. 28
R18-PM fuse with a variety of target membranes including ROS disk membranes, disk rim-specific vesicles, and disk lipid recombinant vesicles containing peripherin/rds. The preparation of these target vesicles is described below.
Disk Membranes. Disk membranes are routinely isolated during the
preparation of plasma membrane from a continuous sucrose density gradient at 30% sucrose. 22 In our experience, 50 frozen bovine retinas routinely
yield 20-25 mg of disk membrane rhodopsin. The disk membranes are
washed free of sucrose and resuspended in calcium chelating buffer 23 to a
rhodopsin concentration of 2.5 mg/ml for phosphate determination and
diluted with chelating buffer to a final phosphate concentration of 1 mM
for fusion assays.
Disk Rim-Specific Vesicles. Rim-specific vesicles have a protein content
that closely mimicks the protein content of the disk rim region, i.e., enriched
in peripherin/rds, 29'3° rom-1, 31 and the rim-ABC protein, 32 with negligible
levels of rhodopsin. These vesicles are prepared from disk membranes
isolated as described in the preceding section. The disk membranes are
solubilized with octylglucoside (OG) and the solubilized mixture subjected
to concanavalin A affinity chromatography. 33'34The unbound fraction from
the concanavalin A column 9 contains total disk lipids and the peripherin/
rds and rom-1, which do not bind to the column. This unbound fraction is
collected and concentrated to a final volume of 5-8 ml, using an Amicon
(Danvers, MA) concentrator (YM10 filter). Disk rim-specific vesicles form
spontaneously after the removal of OG by dialysis for 24-48 hr against
1 M NaC1, 10 mM HEPES, pH 7.4, with two changes of buffer. The rimspecific vesicles are not used for fusion unless the residual OG concentration
(determined as described 35) is less than 0.05 mol% relative to phospholipid.
If the OG concentration is higher, the vesicles are dialyzed for an additional
24 hr in the presence of SM-2 BioBeads (Bio-Rad, Hercules, CA). After
dialysis, the vesicles are subject to five freeze-thaw cycles [liquid nitrogen
(freeze)/room temperature (thaw)]. The volume of vesicles is adjusted with
calcium chelating buffer to a final phospholipid concentration of 1 mM.
Peripherin/rds Recombinants. Peripherin/rds is purified from bovine
retinas by a combination of concanavalin A affinity chromatography and
29 G. Connell and R. S. Molday, Biochemistry 29, 4691 (1990).
30 K. Arikawa, L. Molday, R. S. Molday, and D. S. Williams, Z Cell. Biol. 116, 659 (1992).
3~ O. L. Mortiz and R. S. Molday, Invest. Ophthalmol. Vis. Sci. 37, 352 (1996).
32 M. Illing, L. Molday, and R. S. Molday, J. Biol. Chem. 272, 10303 (1997).
33 A. J. Adams, M. Tanaka, and H. Shichi, Exp. Eye Res. 27, 595 (1978).
34 B. J. Litman, Methods Enzymol. 81, 150 (1982).
35 M. A. Jermyn, Anal Biochem. 68, 332 (1975).
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chromatofocusing techniques. 9 Nonphosphorylated peripherin/rds is isolated from the chromatofocusing column at its pI of 4.7, and phosphorylated
peripherin/rds at a pI of 4.21. Peripherin/rds and phosphoperipherin/rds
recombinants are prepared by detergent dialysis.36 In the preparation of
peripherin/rds recombinants, the purified protein is recombined with
vesicles prepared from extracted disk membrane lipids. 12 Since retinal
has been shown to induce lipid-mediated fusion in photoreceptors, we
reduce the retinal Schiff-base linkage with NaCNBH3, 37 thereby eliminating any retinal-induced effects on fusion. To prepare disk lipid
small unilamellar vesicles (SUVs) for recombination, freshly prepared 2
M NaCNBH3 in 1 M acetic acid is added to freshly isolated disk
membranes in a 2:1 (v/v) ratio in the dark and allowed to sit at room
temperature for 45 min. The treated disk membranes are washed and
resuspended in 10 mM HEPES, pH 7.4, and extracted with 2:1 chloroform-methanol. 26 The extracted lipids are dried under a stream of
nitrogen, lyophilized overnight, and resuspended in 10 mM HEPES, pH
7.4. SUVs are prepared from the liposomes. 38 If necessary, the amount
of residual retinal(ol) can be quantitated by high-performance liquid
chromatography (HPLC). 39
The disk lipid SUVs are recombined with purified peripherin/rds, isolated by chromatofocusing. The peripherin/rds-containing fractions are
combined and the pH adjusted to 7.0 with 0.1 M imidazole, pH 8.0. The
sample is concentrated to one-tenth its original volume with a Centricon
30 filter device (30,000 MW cutoff filter). The ultrafiltration device is centrifuged at 7500g at 4°, time variable, using a fixed-angle rotor. The concentrated purified peripherin/rds in 20-30 mM OG is added to disk lipid SUVs
with vigorous vortexing and the mixture placed in an ice bath for i hr. The
resulting solution should be cloudy, indicating that the OG concentration in
the recombinant is below the critical micelle concentration of the detergent.
Routinely, a ratio of I mol of peripherin/rds to 100-300 mol of phospholipid
is used. The recombinant is then dialyzed against 10 mM HEPES, 0.5 M
NaC1, pH 7.4, for 24-48 hr, with three changes of buffer, with the final buffer
change containing SM-2 BioBeads (Bio-Rad). Under these experimental
conditions, less than 0.05% OG remains associated with the recombinants.
The recombinant-containing peripherin/rds in the disk lipid vesicles is purl36 M. Jackson and B. J. Litman, Biochemistry 21, 5601 (1982).
37 R. S. Fager, P. Sejnowski, and E. W. Abrahamson, Biochem. Biophys. Res. Commun. 47,
1244 (1972).
38y . Barenholtz, D. Gibbs, B. J. Litman, T. Thompson, and F. D. Carlson, Biochemistry 16,
2806 (1977).
39 K. Boesze-Battaglia, S. J. Fliesler, L. Jun, J. E. Young, and P. L. Yeagle, Biochim. Biophys.
Acta 1111, 256 (1992).
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fled on a continuous 10-40% (w/w) sucrose density gradient, spun at 25,000
rpm for 8 hr at 4°. The recombinant is routinely isolated as a single band
at approximately 20-30% sucrose, depending on the final phospholipid/
protein ratio. Peripherin/rds in the recombinant is oriented asymmetrically,
such that all of the peripherin/rds molecules are inserted with their extradiskal side out. This orientation is confirmed by immunofluorescence with
anti-peripherin/rds monoclonal antibody 2B6 to the C terminus (generously
provided by R. Molday29) or by trypsinolysis.9'1°The peripherin/rds recombinants are subject to five freeze-thaw cycles: rapid freezing in liquid nitrogen followed by thawing at room temperature to form large unilamellar
vesicles called peripherin/rds LUVs. Disk lipid vesicles containing no
peripherin/rds or rhodopsin recombinants, which do not to fuse with RasPM, are used a s c o n t r o l s . 9A2'36

R18 Fusion Assay
Fusion between R18-PM and target membranes is detected as an increase in fluorescence intensity at 586 nm on dilution of R18 throughout
the target membrane. In designing these assays it is essential that the amount
of lipid in the RIs-PM be 50-fold lower than the amount of phospholipid in
the target membranes. Therefore, we routinely adjust the phospholipid
concentration of the target membrane to i mM. The assays are performed
in a total volume of either 3 or 1 ml. The calcium concentration of the
target membrane is adjusted by the addition of CaCI2 to the cuvette prior
to or simultaneously with the initiation of fusion. Fluorescence and light
scattering are monitored with Aex 560 nm and ~em 586 nm on a PerkinElmer (Norwalk, CT) LS50 B spectrofluorimeter or equivalent.
The target membranes are equilibrated to the appropriate temperature
while stirring in a thermostatted cuvette turret. Fusion is initiated by the
addition of 50/.d of R18-PM to this suspension of target membrane. The
change in R18 fluorescence is monitored continuously and increases linearly
as the probe dilutes into the target membrane (see Fig. 1). The increase
in observed fluorescence intensity is proportional to the membrane fusion. 6'2~The fluorescence intensity of the target membrane without addition
of plasma membrane is taken as baseline fluorescence and is equal to 0%
fusion. Fluorescence at 100%, equal to 100% fusion, is determined by the
addition of 100/A of 10% Triton X-100 to the membrane mixture. Triton X100 does not interfere with rhodamine fluorescence and the only correction
factor required is that due to dilution. The initial rate of fusion (IRF) is
determined as the percent increase in fluorescence intensity as a function
of time zl as shown in Eq. (1).
IRF = [slope R18/(F0 - Ff)] × 100

(1)
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FIG. 1. Membrane fusion between R18-PM and ROS disk membranes. A representative
tracing of the change in fluorescenceobserved with the R18lipid mixingassay, at 37°, is shown.
(a) Fusion is initiated with the simultaneous addition of R18-PM and calcium ( [ C a 2 + ] f r e e =
45 mM) to the disk membranes. (b) The addition of Triton X-100. [Reprinted with permission
from K. Boesze-Battaglia, A. D. Albert, and P. L. Yeagle, Biochemistry 31, 3733 (1992);
American Chemical Society.]

where slope R18 is equal to the linear change in R18 fluorescence over time,
F0 is the fluorescence intensity at baseline (i.e., in the absence of labeled
Rls-PM), and F~ is the fluorescence intensity on the addition of Triton X100. If a lag time is observed the slope R18 is determined only after the
lag phase.

Analysis of Fluorescence Data
The parameters obtained from the fluorescence data used to characterize the fusion process are as follows: (1) the initial rate of fusion, determined
from the slope of the fluorescence increase (Figs. 1 and 2), (2) the extent
of fusion, determined on an overnight incubation between R18-PM and
target membranes, and (3), in some cases, the lag time prior to the initiation
of fusion (Fig. 2).
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FIG. 2. Membrane fusion between R18-PM and peripherin/rds recombinants. A representative tracing of the increase in fluorescence intensity of Rls at 592 nm over time (minutes) on
the addition of Rls-PM (at 15 sec) to peripherin/rds recombinants is shown at 30 and 37°.
The horizontal solid lines indicate the lag times. The initial rate of fusion is calculated from
the slope of the change in fluorescence intensity after the lag time indicated. [Reprinted
with permission from K. Boesze-Battaglia, O. P. Lamba, A. Napoli, S. Sinha, and Y. Guo,
Biochemistry 37, 9477 (1998); American Chemical Society.]

Characteristics of Fusion between Rls-Labeled Plasma Membrane
and Target Membranes
F u s i o n b e t w e e n R l s - P M and the target m e m b r a n e s share c o m m o n
characteristics: f u s i o n increases linearly o v e r time, requires n a n o m o l a r levels o f calcium, and is c o m p l e t e l y i n h i b i t e d b y the addition o f 1 0 0 / z l o f
1 M E G T A . F u s i o n is t e m p e r a t u r e d e p e n d e n t , with the h i g h e s t initial rates
at 37 ° and a l m o s t n o detectable f u s i o n a b o v e 45 ° or b e l o w 30 ° .
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TABLE I
COMPARISON OF R18-LABELED PLASMA MEMBRANE FUSION WITH VARIOUS
TARGET MEMBRANESa

Target membrane

Addition

Lag time (sec)

IRF (%) = AF/time

Disks
Rim-specific vesicles
Peripherin/rds LUVs

10/zM Ca 2+
10/zM Ca 2+
10/zM Ca 2+

<20
20-50
120

2.9 _+ 0.04
0.26 _+ 0.02
0.30 _+ 0.03

a Fusion of R18-PMs with disk membranes,12isolated rim-specific vesicles, and peripherin/
rds recombinant LUVs23 at 37°. The initial rate of fusion is given as the percent change
in fluorescence intensity per unit time (minutes with disk membranes and seconds with
rim-specific vesicles and peripherin/rds LUVs).

Disk Membranes. A representative tracing of the increase in fluorescence intensity observed upon the fusion of R18-PM with isolated disk
membranes 6 is shown in Fig. 1. Fusion is initiated by the simultaneous
addition (Fig. 1, la) of R18-PM and calcium to a suspension of disk
membranes at 37°. Maximal fusion is determined by the addition of
Triton X-100 (Fig. 1, lb). The slope of the fluorescence increase is used
to calculate the initial rate of fusion. The fusion between disk membranes
and R18-PM can be inhibited by modifications of endogenous peripherin/
rds, such as trypsinolysis of the disk membranes, 9'1° the addition of antiperipherin monoclonal antibody 2B6, 9 or the addition of low concentrations of the peptide PP-5,1° corresponding to amino acids 311 to 325 of
bovine peripherin/rds.
Disk Rim-Specific Vesicles or Peripherin/rds Recombinants. When
R~s-PM fuse with either rim-specific vesicles or peripherin/rds recombinants, a qualitatively different fluorescence pattern is observed as shown
in Fig 2. When fusion of R~8-PM with peripherin/rds recombinants is
measured at 37° a lag phase lasting 120 sec occurs, during which time little
or no fusion is observed. 1° This lag time increases to almost 300 sec when
the temperature is lowered to 30°. Similar results are obtained with rimspecific vesicles, with the exception that the lag phase is shorter in duration;
for example, at 37°, the lag phase is 60-100 sec. A comparison of these
parameters is given in Table I.
To ensure that the observed lag phase results from fusion-related events,
both the temperature dependence and the effect of proteolysis or phospholipase treatment on fusion should be analyzed. A lag in the onset of fusion
should increase when the temperature is lowered. If the fusion is protein
mediated, the lag phase would also change in duration on proteolysis of
the proposed fusion protein. Conversely, if the fusion is lipid mediated

[5]
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then any alteration in lipid properties after phospholipase treatment would
affect a true lag phase.
Critical Notes Regarding Rls Dequenching Assay
The use of endogenous probes for the measurement of membrane fusion
requires that a number of critical factors be considered and controls designed to account for specious results. Under some experimental conditions,
a spontaneous transfer of R~8 between membranes can occur in the absence
of membrane merging and fusion.4° Such transfer has not been seen to any
appreciable extent with R18-PM, when these membranes are incubated
with phosphatidylcholine LUVs. 6 In our experience, spontaneous transfer
of R18 from plasma membrane vesicles to phosphatidylcholine SUVs or
LUVs is indicative of permeable vesicles due to prolonged storage (longer
than 24 hr).
Fusion should also be confirmed by alternative techniques, i.e., sucrose
density gradient centrifugation (allows the separation of fused from
unfused species 1132) or microscopy.17'18 Alternatively, the addition of
high concentrations of unlabeled plasma membrane should inhibit Ra8
dequenching, indicating that the increase in fluorescence was due to the
merger of two membranes. Conversely, binding of Rls-labeled membranes
to the target membrane should result in no dequenching or in a nonlinear
change in R18 fluorescence. Investigators are strongly encouraged, when
possible, to compare different fusion assays in the same system and to
characterize known fusion properties of the membranes (i.e., specific
inhibitors, temperature dependence, cation dependence, membrane specificity).

Characterization of Molecular Basis of
Peripherin / rds-Mediated Fusion
Peripherin/rds is the first rod cell-specific fusion protein to be identified.
Fusion is mediated through at least one region of peripherin/rds, from
residues 311 to 325. A peptide analog to this region, called PP-5, promotes
membrane adhesion and membrane destabilization,9,1°,13 two prerequisite
steps for fusion.41
An initial strategy in the identification of a candidate fusion protein
and subsequent characterization of a fusogenic region within such a protein
relies on proteolysis studies. Trypsinolysis of peripherin/rds led to the
4oA. Loyter,V. Citovsky,and R. Blumenthal,Methods Biochem. Anal 33, 128 (1988).
41j. Bentz and H. Ellens, Colloids Surf. 30, 65 (1988).
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identification of a fusion-promoting region. 9,1° The target membranes are
incubated with trypsin (final concentration, 0.2 ~g/ml) for 30 min in the
dark at 37°. The reaction is stopped by the addition of trypsin inhibitor
(final concentration, 0.4 mg/ml), and the samples are washed in 10 mM
HEPES, pH 7.2, and centrifuged at 60,000 rpm for 40 min. The pellet is
resuspended in 10 mM HEPES, pH 7.2, for the fusion assay; the supernatant
containing the tryptic fragments is reserved on ice. Trypsinolysis of disk
membranes and peripherin/rds recombinants under these conditions results
in the cleavage of a 12.5-kDa band immunoreactive with anti-peripherin/
rds antibody 2B6, which was found to correspond to the C terminus of
peripherin/rds. Cleavage of this peptide fragment inhibited fusion of disks
and peripherin/rds recombinants with Rls-PM. l° Fusion activity is restored
with the subsequent addition of the tryptic fragments at a ratio equal to that
in the native membrane. 1°The size of the tryptic fragments is determined by
gradient gel electrophoresis42 and/or H P L C . 43 Such experiments provide
evidence that the tryptic fragments contain a fusion-promoting region of
peripherin/rds that retained biological activity, as determined on the basis
of the restoration of fusion activity, and led to the synthesis of overlapping
C-terminal peptides (Table II).

Peptide-Induced Aqueous Contents Mixing as Measure of Fusion
The fusion-promoting activity of tryptic fragments and synthetic peptides is evaluated directly in an assay measuring the mixing of the aqueous
contents of model membranes. This approach allows the investigator to
determine if a peptide satisfies both criteria for fusion, i.e., membrane lipid
and aqueous contents mixing. A fluorescence-based contents mixing assay
using 8-aminonaphthalene-l,3,6-trisulfonic acid andp-xylene bispyridinium
bromide (ANTS and DPX, respectively) has been chosen since these membranes are not biologically active. This assay is based on the principle that
the fluorescence of one probe, ANTS, is quenched by a second probe,
DPX; such probes are called quenching pairs. 44 The two fluorophores are
encapsulated separately into two different populations of vesicles. On fusion
and contents mixing a collisional quenching of the ANTS occurs and is
detected as a decrease in fluorescence.44'45

42 H. Schagger and G. von Jagow, Anal. Biochem. 166, 368 (1987).
43 j. H. McDowell, J. P. Nawrocki, and P. A. Hargrave, Biochemistry 32, 4968 (1993).
4~ H. Ellens, J. Bentz, and F. C. Szoka, Biochemistry 23, 1532 (1984).
45 F. Szoka, F. Olson, T. Heath, W. Vail, E. Mayhew, and D. Papahadjopoulos, Biochim.
Biophys. Acta 601, 559 (1980).
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Materials
ANTS: 8-Aminonaphthalene-l,3,6-trisulfonic acid, disodium salt (Molecular Probes); store in dark
DPX: p-Xylene bispyridium bromide (Molecular Probes); store in dark
PS: Phosphatidylserine (bovine brain; Avanti Polar Lipids, Alabaster, AL)
N-Methyl-DOPE: N-Monomethyldioleoylphosphatidylethanolamine
(Avanti Polar Lipids)
ANTS buffer: 10 mM Glycine, 45 mM NaC1, 25 mM ANTS, pH 9.5
DPX buffer: 10 mM Glycine, 90 mM DPX, pH 9.5

Preparation of ANTS- or DPX-Containing Vesicles
Large unilamellar vesicles (LUVs) encapsulating either ANTS or DPX
are prepared from 95 mol% N-methyl-DOPE and 5 mol% PS (bovine
brain). 45,46 The dried lipids are resuspended in buffer containing either
ANTS or DPX, subjected to five freeze-thaw cycles in liquid nitrogen, and
extruded through a polycarbonate filter (Poretics, Pleasanton, CA; 467 mm,
pore size 0.1/zm), using a Nuclepore (Pleasanton, CA) 47-mm in-line filter
holder. 45 Encapsulated fluorescent probe is separated from unincorporated
probe on a Sephadex G-50 column eluted with 100 mM NaC1, 10 mM
glycine, and 0.1 mM EDTA, pH 9.5. The vesicles containing the encapsulated probe elute with the void volume. Both the ANTS-containing and
the DPX-containing vesicles are resuspended in 10 mM glycine, pH 9.5, to
a final 1 mM phosphate concentration. The pH of the solutions must be
accurate since N-monomethyl-DOPE will form nonbilayer structures below
pH 8.0, resulting in vesicle aggregation.

A N T S - D P X Contents Mixing Assay
Fluorescence intensity is monitored at Aex 380 nm and hem 510 nm. In
a 3-ml fusion reaction mixture, the thermostatted cuvette contains 30 tzl
of ANTS-containing vesicles, 270/zl of DPX-containing vesicles, and 2.7
ml of column buffer (100 mM NaCI, 10 mM glycine, and 0.1 mM EDTA,
pH 9.5). Fusion is initiated by lowering the pH of the fusion mixture from
9.5 to 4.5 (Fig. 3a) by the addition of 2 M sodium acetate-acetic acid
(25-50 tzl). Fusion is measured as a decrease in fluorescence intensity as
the aqueous contents are mixed and an ANTS-DPX complex is formed.
Baseline fluorescence is the intensity obtained with the shutters closed.
The 100% fluorescence level is the initial fluorescence intensity before
46 H. Ellens, J. Bentz, and F. C. Szoka, Biochemistry 24, 3099 (1985).
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FIG. 3. Membrane fusion detected by aqueous contents mixing of ANTS- and DPXcontaining vesicles. Shown is a representative tracing of the decrease in fluorescence at 510
nm over time (seconds) as the pH of the fusion mixture (ANTS vesicles and DPX vesicles)
is lowered with 2 M sodium acetate (a) at 37°.

lowering the pH. The IRF between ANTS- and DPX-containing vesicles
is calculated as shown in Eq. (2)47:
I R F = [slOpeANTS/DPx/(F~ - Fo)] × 100

(2)

where slopegyrs/oPx is equal to the linear change in ANTS fluorescence
over time, F0 is the fluorescence intensity prior to the initiation of fusion
with acetic acid and Ft is the fluorescence intensity with the shutters closed.
Effect o f Peripherin/rds Peptides on A N T S - D P X

Fusion

To determine if the various synthetic peptides to the C terminus of
peripherin/rds are fusogenic, the A N T S - D P X fusion mixture is preincubated with the peptide at the desired temperature prior to the initiation of
fusion. Routinely, the effect of a single peptide concentration on fusion is
studied within a temperature range of 28 to 42°. The peptide concentrations
used are in the millimolar to nanomolar range. Such studies, while necessary
47 D. Kelsey, T. Flanagan, J. E. Young, and P. L. Yeagle,

Virology 182, 690 (1991)•
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to describe a mechanistic pathway, should be performed to complement
the fusion assays described above.

ANTS-DPX Fusion. Transient perturbations, analogous to hemifusion,
can be distinguished from fusion by A N T S - D P X leakage assays. 48 The
A N T S - D P X assay cannot be used to measure aqueous contents mixing of
SUVs because ANTS binds excessively to such v e s i c l e s . 49
Synthetic Peptides. To confirm the specificity of a peptide-induced fusion,
a scrambled peptide (same amino acids in a different sequence), a fusogenic
peptide from a different system, e.g., a viral fusion peptide, or a nonspecific
peptide at high concentration should be tested. The fusogenic peptide
should produce an effect at physiologically relevant peptide concentrations.
Peptide-induced fusion in a model membrane system should affect fusion
in the biological cell-free assay system. In photoreceptors, PP-5 inhibits
fusion between disk and R18-PM when added in a 1 : 1 ratio with peripherin/
rds. 1° The secondary structure of the peptide should be evaluated in the
fusion mixture and an effort made to denature this structure and show that
the denatured species is unable to induce fusion.
Peripherin/rds Mutagenesis
Fusion-promoting region(s) of peripherin/rds can also be identified by
mutagenesis. Peripherin/rds mutagenesis studies require a viable cell expression system in which the fusion competence of the cells or of the
proteins harvested from the cells can be determined. The protocol for the
determination of this fusion competency in Madin-Darby canine kidney
(MDCK) cells is given below. A similar strategy can potentially be employed to characterize other cell expression systems.

Establishment of Fusion Competency of MDCK Cells Expressing
Human Peripherin/rds
MDCK strain II cells stably transfected with human peripherin/rds with
an Xpress N-terminal tag 5° have been generously provided by R. Kim. The
peripherin/rds is localized to the basolateral MDCK plasma membrane,
and oriented with the N-terminal epitope tag and the C terminus on the
48j. Zhao, S. Kimura, and Y. Imanishi, Biochim. Biphys. Acta 1283, 37 (1996).
49 N. Diizgiine§ and J. Bentz, in "Spectroscopic Membrane Probes" (L. M. Loew, ed.), Vol.
1, p.117. CRC Press, Boca Raton, Florida, 1988.
50 R. Y. Kim, Invest. Ophthalmol. Vis. Sci. 39, $677 (1998).
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extracellular surface. 5° MDCK cells expressing human peripherin/rds are
grown to confluence in Dulbecco's modified Eagle's medium (DMEM),
supplemented with 10% fetal bovine calf serum, and isolated by scraping.
The cells cannot be harvested with trypsin, since trypsinolysis hydrolyzes
the fusogenic domain of peripherin/rds. The cells are resuspended in 145
mM NaCl, 5 mM KCI, 10 mM HEPES, pH 7.4. Fusion between whole
MDCK cells and Rls-PM is measured as described above. On the addition
of ROS R18-PM to peripherin/rds-expressing MDCK cells at 37° an increase
in R18 fluorescence was observed. The initial rate of fusion under these
conditions is 0.35 _ 0.040 AF(fluorescence)/sec. Fusion between R18-PM
and peripherin/rds-expressing cells is inhibited by the addition of 1.0 mM
E G T A and by trypsinolysis of the MDCK cell plasma membranes. Fusion
is not detected with R~8-PM and MDCK cells containing no peripherin/
rds. The R18 fluorescence profile seen in these assays is qualitatively similar
to that shown in Fig. 2, with a lag time of 60-90 sec.

Resonance Energy Transfer-Based Lipid Mixing Assay
The R18 dequenching assay described above requires large quantities
of MDCK cells and may not be usable if fewer cells are available. An
alternative technique requiring less material and relying on resonance energy transfer (RET) may be used. Detection of lipid mixing by RET requires
that two membrane preparations be labeled with a fluorescent probe at
non-self-quenching concentrations. In the RET assay, pairs of fluorophores
are used in which one fluorophore, designated the energy donor, has an
emission band that overlaps with the excitation band of the second fluorophore, called the energy acceptor. 51,52When these two fluorophores are in
close proximity, as would occur in membrane bilayers on fusion and lipid
mixing, there is a transfer of the excited state energy from a donor to an
acceptor) 3 Thus the acceptor fluorophore fluoresces as though it has been
excited directly. A large number of lipid probes satisfies the criteria for
efficient energy transfer, and they are called energy transfer couples, as RET
between two fluorophores has a number of advantages 51-53when compared
with the R18 lipid mixing assay for use in the MDCK cell system: (1) The
RET method is extremely sensitive, requiring only small quantities of
target membrane since the ratio of the two membranes undergoing
fusion is equal; and (2) RET assays are adapted to be performed in

51 L. Stryer, Annu. Rev. Biochem. 47, 819 (1978)
52 T. Z. Forster, Naturforsch. A 4A, 321 (1949).
53 D. Hoekstra, Biochemistry 21, 1055 (1982).
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96-well plates, using a fluorescence plate reader in a total fusion reaction
volume of 200 ~1. 54
Two approaches have been described in using RET techniques. In
the first, a single membrane species is labeled with two fluorophores55;
in the second, the fluorophores are incorporated into two separate
membrane species and fusion is detected as an increase in fluorescence
intensity of the acceptor fluorophore. 54'56 In the MDCK cell system we
have employed the latter approach, using R18-PM and Fls-labeled MDCK
cell plasma membranes, with a fluorescence plate reader at room temperature.54,56

Labeling of MDCK Cells and Rod Outer Segment Plasma
Membrane with Fluorescent Membrane Probes
Purified ROS plasma membrane vesicles are labeled with R18 exactly
as described above, with the exception that the concentration of Ra8 incorporated is equal to 0.8 to 1.0% relative to the membrane phospholipid.
Unincorporated R18 is removed by chromatography on a Sephadex G-75
column (total volume of the column, 1-2 ml).
The stably transfected MDCK cells expressing human peripherin/rds
are grown to confluence and isolated by scraping. The cells are resuspended
in 145 mM NaCI, 5 mM KC1, 10 mM HEPES, pH 7.4, and labeled with
5-(N-octadecanoyl)aminofluorescein (F18), following the same protocol as
described above for R~8-1abeled plasma membrane. The F18 is added at
0.80-1.0 mol% relative to phospholipid in the MDCK cells. Routinely,
phospholipid phosphate 24'25 is determined for each experiment and correlated to cell number. The F~8 is removed by chromatography on a Sephadex
G-75 column (total volume of the column, 1-2 ml).

Rls-Fls Fusion Assay
Fusion between R18-1abeled plasma membrane and Fls-labeled MDCK
cells is measured on a Perkin-Elmer LS 50B spectrofluorimeter equipped
with a fluorescence plate reader (model L225 0137). Fusion is initiated by
the addition of RIs-PM to F~8-1abeled MDCK cells present in the 96-well

54 M. A. Partearroyo, E. Cabezon, J. L. Nieva, A. Alonso, and R. M. Foni, Biochim. Biophys.
Acta 1189, 175 (1994).
55 A. J, M. Driessen, D. Hoekstra, G. Scherphof, R. D. Kalicharan, and J. Wilschut, J. Biol.
Chem. 260, 10880 (1985).
56 V. Litwin, K. Nagashima, A. M. Ryder, C. Chun-Huey, J. M. Carver, W. C. Olson,
M. Alizon, K. Hasel, P. J. Maddon, and G. P. Alloway, J. Virol. 70, 6437 (1996).
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plates. The change in fluorescence intensity is measured continuously for
2-10 min with &x 470 nm (F18 excitation) and at ~em 524 nm (emission
wavelength F18) and ~em 592 nm (emission wavelength R18). The fluorescence intensity obtained with double-labeled plasma membrane is taken
as maximal fusion. The extent of fusion (R) is calculated as shown in

Eq. (3)54:

e = [(/592//524) -t-/592]t - [(/592/I524) -I-/592]c

(3)

where •524 and 1592 are the fluorescence intensities at 524 and 592 nm,
respectively. The subscripts c and t represent the initial time point and any
time thereafter, respectively. On fusion, fluorescence intensity increases at
592 nm and decreases at 524 nm, with the /~ex Of 470 nm. To confirm that
resonance energy transfer is occurring the emission scan of R18 from 500
to 680 nm is recorded. This assay may be performed on a larger scale in
a thermostatted cuvette or on coverslips. 56

Advantages of MDCK Cell Line
Peripherin/rds expressed in COS-1 cells is localized to the intracellular
membranes and is abnormally glycosylated.57 For studying fusion processes
the MDCK cell line has some important advantages over COS-1 cells: (1)
In MDCK cells, peripherin/rds is also expressed on the plasma membrane
surface, thus allowing whole cells to be used in fusion assays and easier
manipulation of the membranes; (2) MDCK cells are stably transfected with
human peripherin/rds, allowing a direct correlation between the fusionpromoting activity of peripherin/rds and human peripherin/rds diseaselinked mutations; and (3) the human peripherin/rds expressed in MDCK
cells is glycosylated and forms dimers as occurs in native photoreceptors. 5°

Pitfalls of Expression Systems
COS-1 and MDCK cells allow production of large quantities of
peripherin/rds and peripherin/rds mutants for recombination and subsequent fusion studies. In addition to the commonly encountered shortcomings of cell expression systems, localization of peripherin/rds to the intracellular membranes of COS-1 cells may result in artifactual characterization
of peripherin/rds-mediated fusion processes owing to the presence of
endogenous proteins involved in other fusion processes. For example, in
COS-1 cells peripherin/rds is localized to the intracellular membranes,

57 A. F. X. Goldberg, L. Moritz, and R. S. Molday, Biochemistry 34, 14213 (1995).
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which also contain a family of intracellular fusion proteins 58,59 that may
inhibit or enhance peripherin/rds-mediated fusion. In lieu of another expression system, such shortcomings can be overcome by characterizing in
detail the specificity of the fusion pathway. Although the overexpression
of the fusion protein may be essential for the isolation of large quantities
of protein, membrane fusion processes dependent on this protein may
actually be inhibited by excessive amounts of expressed protein. This possibility becomes more likely if a specific oligomeric form of the protein is
required for fusion competency.

Pitfalls of Resonance Energy Transfer Assays
To identify and exclude extensive membrane aggregation as a contributor to energy transfer, E G T A or E D T A , known to decrease peripherin/
rds-promoted vesicle aggregation, would selectively decrease R E T efficiency due to aggregation. In pure liposome preparations, changes in the
behavior of the membrane lipids may alter the quantum efficiency of various
fluorophores, with changes in fluorescence observed due to factors other
than fusion. 6°

Analysis of Individual Steps Contributing to Membrane Fusion
Once a region of a candidate fusion protein has been shown to promote
fusion, the ability of this region to mediate the individual steps in fusion
can be evaluated, taking into consideration the four steps of membrane
fusion41: (1) aggregation of the fusing membranes, (2) close approach of
the lipid bilayers, (3) destabilization of the membrane bilayer at the point
of fusion (two bilayers that are closely opposed may not necessarily fuse),
and (4) mixing of the components of the lipid bilayer and of the aqueous
contents, to form a new structure. The protocols below describe how two
mechanistic criteria necessary for fusion, membrane aggregation and destabilization, 61 were met for PP-5.

Membrane Aggregation-Adhesion
The Ca2+-dependent aggregation of SUVs or LUVs can be monitored
continuously as a change in absorbance at 380 nm in a Perkin-Elmer 2.0
UV/Vis spectrometer or equivalent equipped with a thermostatted cu58M. Liniai, J. Neurochem. 69, 1781 (1997).
59T. Sollner,S. W. Whiteheart,M. Brunner,H. Erdjument-Bromage,S. Geromanos,P. Tempst,
and J. E. Rothman, Nature (London) 362, 318 (1993).
60D. Hoekstra and N. Diizgiine§,Methods Enzymol. 220~15 (1993).
61y. Kliger,A. Aharon, D. Rapaport, P. Jones, R. Blumenthal,and Y. Shai, J. Biol. Chem.
272, 13496 (1997).
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vette holder. As the vesicles aggregate and become larger an increase in
scattered light is detected as a change in absorbance, recorded every 0.1
min for 10 min. 23 The SUVs are composed of phosphatidylcholinephosphatidylserine-cholesterol (PC: PS : Chol, 4:4 : 1; final phosphate concentration, 1.5 mM). 1°A3 Aggregation is initiated with the addition of
CaC12 (final concentration, 16 /zM Ca2+). Reversible aggregation is
distinguished from fusion by the addition of 1 M EDTA to a final
concentration of 33 mM and the absorbance is monitored for an additional
3 min. To determine the effect of individual peptides on aggregation,
the vesicles are preincubated with peptide for 10 min at the indicated
temperatures prior to the addition of calcium. The kinetic parameters
of membrane adhesion can be directly calculated from the fluorescence
data obtained in the R~8 lipid mixing experiments, assuming a mass
action kinetic model. 62

Membrane Bilayer Destabilization
Membrane bilayer destabilization can be inferred fluorimetrically with
the fluorescent dye 3,3'-diethylthiodicarbocyanine iodide (diS-C2-5; Molecular Probes) as a collapse in a valinomycin-induced diffusion potential in
model membranes. 61'63 SUVs composed of PC : PS : Chol in a 4: 4 : 1 molar
ratio are prepared by probe sonication in the presence of K+-containing
buffer (50 mM K2SO4, 10 mM HEPES-SO4, pH 6.8). 38 An aliquot of the
SUVs (phospholipid concentration, 36 nmol) is added to 10 ml of isotonic
buffer (50 mM Na2SO4, 10 mM HEPES-SO4, pH 6.8) containing 10/~1 of
the fluorescent probe diS-C2-5 (stock, 1 mM) and incubated at 37° until a
stable baseline fluorescence is established. The addition of valinomycin to
a final concentration of 10 -7 M selectively permeabilizes the vesicles to K ÷,
creating a negative diffusion potential inside the vesicles and resulting in
the quenching of the fluorescence of the dye. Peptides from a 1-mg/ml
stock in either distilled H20 or K+-free buffer are added in 25-, 75-, or 100/xl aliquots. Fluorescence is recorded at Aex 620 nm and/~em 670 nm for 90
min after the addition of the various peptides. An increase in fluorescence
intensity on the addition of peptides is indicative of a dissipation of the
diffusion potential due to peptide-induced destabilization. To quantitate
the total fluorescence recovered, fluorescence is monitored before the addition of valinomycin, after the addition of valinomycin, and after the addition
of the desired peptide. The percent fluorescence recovery is calculated 61
as shown in Eq. (4):
62 S. Nir, K. Klappe, and D. Hoekstra, Biochemistry 25, 8261 (1986).
63 L. M. Loew, I. Rosenberg, M. Bridge, and C. Gitler, Biochemistry 22, 837 (1983).
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Io)/(If-

(4)

Ft = [ ( I t -

Io)] x 100

It is the fluorescence after the addition of the peptide, at time t, I0 is

fluorescence after the addition of valinomycin, and If is the fluorescence
intensity prior to the addition of valinomycin. Mellitin (final concentration,
9.0/zg/ml) is added to confirm that the increase in fluorescence observed
is due to a collapse in the diffusion potential. Mellitin should dissipate the
valinomycin-induced diffusion potential even after the addition of those
peptides that have no destabilizing effect.
Membrane destabilization is inferred from the fluorescence experiments
described above. Changes in bilayer structure can be measured directly
using 31p NMR64-66 and freeze-fracture electron m i c r o s c o p y . 67
Conclusions
This chapter has summarized the technical advantages of fluorescencebased fusion assays as applied to retinal rod cells and shown how these
assays led to the identification of peripherin/rds as a photoreceptor-specific
fusion protein. It is important to note an added benefit of this approach,
namely that the data obtained can be readily analyzed in the framework
of a mass action kinetic model for f u s i o n . 68'69 Such a model depicts the
overall fusion reaction as consisting of two distinct steps: a second-order
aggregation reaction and the actual fusion event, which is first order. Spontaneous disk-plasma membrane fusion in the ROS 11 has been shown to
conform to such a model. Therefore, by using a variety of experimental
conditions the rate constants of the aggregation step and fusion can be
calculated, thereby providing greater understanding of the molecular mechanism of fusion in the ROS.
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